Investor Relations

A leadership story in the field of advanced cell therapy

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
May 3, 2019
Document Date
May 1, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vericel Corporation
Issuer
AASTROM BIOSCIENCES INC
Filer
MCLAUGHLIN KEVIN F

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.